Novel Molecular Therapeutics to Modulate Serotonin 5-HT2A Receptor Function

Project: Research project

Project Details

StatusFinished
Effective start/end date4/1/21 → 3/11/22

Funding

  • VidaLibreBio, Inc ( Award # ): $750,252.00